BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu ER, Chou YE, Liu YF, Hsueh KC, Lee HL, Yang SF, Su SC. Association of lncRNA H19 Gene Polymorphisms with the Occurrence of Hepatocellular Carcinoma. Genes (Basel) 2019;10:E506. [PMID: 31277475 DOI: 10.3390/genes10070506] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Pei JS, Chen CC, Chang WS, Wang YC, Chen JC, Hsiau YC, Hsu PC, Hsu YN, Tsai CW, Bau DT. Significant Associations of lncRNA H19 Genotypes with Susceptibility to Childhood Leukemia in Taiwan. Pharmaceuticals (Basel) 2021;14:235. [PMID: 33800276 DOI: 10.3390/ph14030235] [Reference Citation Analysis]
2 Naz F, Tariq I, Ali S, Somaida A, Preis E, Bakowsky U. The Role of Long Non-Coding RNAs (lncRNAs) in Female Oriented Cancers. Cancers (Basel) 2021;13:6102. [PMID: 34885213 DOI: 10.3390/cancers13236102] [Reference Citation Analysis]
3 Wang YC, Tsao SM, Li YT, Lee CY, Tsao TC, Hsieh MJ, Yang SF. The Relationship between Long Noncoding RNA H19 Polymorphism and the Epidermal Growth Factor Receptor Phenotypes on the Clinicopathological Characteristics of Lung Adenocarcinoma. Int J Environ Res Public Health 2021;18:2862. [PMID: 33799753 DOI: 10.3390/ijerph18062862] [Reference Citation Analysis]
4 Tan T, Li J, Wen Y, Zou Y, Yang J, Pan J, Hu C, Yao Y, Zhang J, Xin Y, Li S, Xia H, He J, Yang T. Association between lncRNA-H19 polymorphisms and hepatoblastoma risk in an ethic Chinese population. J Cell Mol Med 2021;25:742-50. [PMID: 33236528 DOI: 10.1111/jcmm.16124] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Deng Y, Zhou L, Yao J, Liu Y, Zheng Y, Yang S, Wu Y, Li N, Xu P, Lyu L, Zhang D, Lyu J, Dai Z. Associations of lncRNA H19 Polymorphisms at MicroRNA Binding Sites with Glioma Susceptibility and Prognosis. Mol Ther Nucleic Acids 2020;20:86-96. [PMID: 32155588 DOI: 10.1016/j.omtn.2020.02.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
6 Bai XF, Niu RZ, Liu J, Pan XD, Wang F, Yang W, Wang LQ, Sun LZ. Roles of noncoding RNAs in the initiation and progression of myocardial ischemia-reperfusion injury. Epigenomics 2021;13:715-43. [PMID: 33858189 DOI: 10.2217/epi-2020-0359] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Li X, Zhang Y, Su L, Cai L, Zhang C, Zhang J, Sun J, Chai M, Cai M, Wu Q, Zhang C, Yan X, Wang L, Huang X. FGF21 alleviates pulmonary hypertension by inhibiting mTORC1/EIF4EBP1 pathway via H19. J Cell Mol Med 2022;26:3005-21. [PMID: 35437883 DOI: 10.1111/jcmm.17318] [Reference Citation Analysis]
8 Lange M, Begolli R, Giakountis A. Non-Coding Variants in Cancer: Mechanistic Insights and Clinical Potential for Personalized Medicine. Noncoding RNA 2021;7:47. [PMID: 34449663 DOI: 10.3390/ncrna7030047] [Reference Citation Analysis]
9 Tsay MD, Hsieh MJ, Lee CY, Wang SS, Chen CS, Hung SC, Lin CY, Yang SF. Involvement of FGFR4 Gene Variants on the Clinicopathological Severity in Urothelial Cell Carcinoma. Int J Environ Res Public Health 2019;17:E129. [PMID: 31878098 DOI: 10.3390/ijerph17010129] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
10 Tietze L, Kessler SM. The Good, the Bad, the Question-H19 in Hepatocellular Carcinoma. Cancers (Basel) 2020;12:E1261. [PMID: 32429417 DOI: 10.3390/cancers12051261] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
11 Ghapanchi J, Ranjbar Z, Mokhtari MJ, Koohpeima F, Derakhshan M, Khademi B, Ghaderi H, Sheikhbahaei S, Aliabadi E. The LncRNA H19 rs217727 Polymorphism Is Associated with Oral Squamous Cell Carcinoma Susceptibility in Iranian Population. Biomed Res Int 2020;2020:1634252. [PMID: 32337223 DOI: 10.1155/2020/1634252] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
12 Janaththani P, Srinivasan SL, Batra J. Long Non-Coding RNAs at the Chromosomal Risk Loci Identified by Prostate and Breast Cancer GWAS. Genes (Basel) 2021;12:2028. [PMID: 34946977 DOI: 10.3390/genes12122028] [Reference Citation Analysis]
13 Huang MC, Chou YH, Shen HP, Ng SC, Lee YC, Sun YH, Hsu CF, Yang SF, Wang PH. The clinicopathological characteristic associations of long non-coding RNA gene H19 polymorphisms with uterine cervical cancer. J Cancer 2019;10:6191-8. [PMID: 31772651 DOI: 10.7150/jca.36707] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
14 Weng WC, Chen CJ, Chen PN, Wang SS, Hsieh MJ, Yang SF. Impact of Gene Polymorphisms in GAS5 on Urothelial Cell Carcinoma Development and Clinical Characteristics. Diagnostics (Basel) 2020;10:E260. [PMID: 32354045 DOI: 10.3390/diagnostics10050260] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Garcia-Lezana T, Lopez-Canovas JL, Villanueva A. Signaling pathways in hepatocellular carcinoma. Adv Cancer Res 2021;149:63-101. [PMID: 33579428 DOI: 10.1016/bs.acr.2020.10.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
16 Hu JC, Lin CY, Wang SS, Chiu KY, Li JR, Chen CS, Hung SC, Yang CK, Ou YC, Cheng CL, Yang SF. Impact of H19 Polymorphisms on Prostate Cancer Clinicopathologic Characteristics. Diagnostics (Basel) 2020;10:E656. [PMID: 32878251 DOI: 10.3390/diagnostics10090656] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Harati-Sadegh M, Kohan L, Teimoori B, Mehrabani M, Salimi S. The effects of placental long noncoding RNA H19 polymorphisms and promoter methylation on H19 expression in association with preeclampsia susceptibility. IUBMB Life 2020;72:413-25. [PMID: 31769935 DOI: 10.1002/iub.2199] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
18 Alipoor B, Parvar SN, Sabati Z, Ghaedi H, Ghasemi H. An updated review of the H19 lncRNA in human cancer: molecular mechanism and diagnostic and therapeutic importance. Mol Biol Rep 2020;47:6357-74. [PMID: 32743775 DOI: 10.1007/s11033-020-05695-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
19 Wang K, Zhu Z, Wang Y, Zong D, Xue P, Gu J, Lu D, Tu C. The influence of LncRNA H19 polymorphic variants on susceptibility to cancer: A systematic review and updated meta-analysis of 28 case-control studies. PLoS One 2021;16:e0254943. [PMID: 34310645 DOI: 10.1371/journal.pone.0254943] [Reference Citation Analysis]